Multi-symptom Cold Relief Tablet, Film Coated
NDC Package 47682-047-99
Package Information
Multi-symptom Cold Relief (acetaminophen, dextromethorphan hbr, phenylephrine hcl , guaifenesin, ,) tablets is usesTemporarily relieves these symptoms due to the common coldheadachenasal congestioncoughminor aches and painssore throatsinus congestion and pressurehelps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make cough more productiveTemporarily reduces fever. This formulation utilizes a tablet, film coated delivery system. Marketed by Unifirst First Aid Corporation, this product is identified by NDC 47682-047 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1098435 - acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet
- RxCUI: 1098435 - acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet
- RxCUI: 1098435 - APAP 325 MG / Dextromethorphan Hydrobromide 10 MG / Guaifenesin 100 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 47682 - Unifirst First Aid Corporation
- 47682-047 - Multi-symptom Cold Relief
- 47682-047-99 - 2 TABLET, FILM COATED in 1 PACKET
- 47682-047 - Multi-symptom Cold Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (47682-047). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 47682-047-99 identifies a specific commercial package of 2 tablet, film coated in 1 packet of Multi-symptom Cold Relief, a human over the counter drug labeled by Unifirst First Aid Corporation. This tablet, film coated is formulated for oral use and contains acetaminophen; dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unifirst First Aid Corporation on September 26, 2022. The current certification is valid through December 31, 2026.
How is this Unifirst First Aid Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 47682004799. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.